ORN Fall 2022 #1 - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl-Recording - #1 - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl

Recording - #1 - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl

Video Transcription

Video Summary

The video content discussed the use of buprenorphine for the treatment of opioid use disorder in an emergency department setting. The presenters, Dr. Jean-Marie Perrone and Dr. Lewis Nelson, discussed the challenges and strategies for initiating buprenorphine in the ED. They highlighted the high mortality rates associated with opioid use disorder and the need for immediate treatment in this population. They discussed the evidence supporting the use of buprenorphine in the emergency department, including studies showing increased engagement in treatment and decreased mortality rates. They also discussed the barriers and potential adverse events associated with buprenorphine initiation, particularly in the context of fentanyl use. To address these barriers, the presenters discussed various strategies, including microinduction, transdermal patches, and the use of extended-release buprenorphine injections. They emphasized the importance of individualizing treatment based on patient factors and the need for ongoing medical support and monitoring. Overall, the presentation highlighted the importance of buprenorphine initiation in the emergency department and provided recommendations for best practices in this setting. (Note: No credits were granted in the video)

Keywords

buprenorphine

opioid use disorder

emergency department

treatment

challenges

strategies

mortality rates

engagement in treatment

adverse events